Literature DB >> 4127260

Letter: Immune response genes in myasthenia gravis.

P O Behan, J A Simpson, H Dick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4127260     DOI: 10.1016/s0140-6736(73)91130-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

Authors:  R C Bucknall
Journal:  Proc R Soc Med       Date:  1977

2.  Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.

Authors:  W M Behan; P O Behan; J A Simpson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

3.  Genetic associations between myasthenia gravis and the HL-A system.

Authors:  R Pirskanen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-01       Impact factor: 10.154

Review 4.  Associations between HL-A histocompatibility antigens and non-malignant diseases.

Authors:  L P Ryder; L S Nielson; A Svejgaard
Journal:  Humangenetik       Date:  1974

5.  Immune disease and HLA associations with myasthenia gravis.

Authors:  P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

6.  Congenital myasthenia gravis: clinical and HLA studies in two brothers.

Authors:  A M Whiteley; M S Schwartz; J A Sachs; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

7.  Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis.

Authors:  L Hammarström; E Smith; E Möller; C Franksson; G Matell; G Von Reis
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

8.  Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.

Authors:  J P Delamere; S Jobson; L P Mackintosh; L Wells; K W Walton
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

9.  HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.

Authors:  G Lamoureux; P Duquette; Y Lapierre; B Cosgrove; G Bourret; L Labrie
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

10.  Familial myasthenia gravis.

Authors:  D Honeybourne; P A Dyer; P D Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.